Citations

Clear

3314 citation(s) found for "Yu, Alexander".

The Surgical Lifeline: Intraoperative Consultation
Moore, Amy M. , Shin, Alexander Y.

Mayo Clinic

Techniques in Hand & Upper Extremity Surgery | April 19, 2021 | Volume: 25 | Issue: 2 | Pages: 61-62

10.1097/bth.0000000000000352 | PMID 33867506 Get It

In Vivo Comparison of Radiation Exposure in Third-Generation vs Second-Generation Dual-Source Dual-Energy CT for Imaging Urinary Calculi
Lam, Jonathan P. , Alexander, Lauren F. , William, Haley E., Hodge, David O. , Kofler, James M., Morin, Richard L. , Thiel, David D. , Cernigliaro, Joseph G. , Alexander, Lauren F

Mayo Clinic

Journal of Endourology | April 16, 2021 | Volume: 35 | Issue: 11 | Pages: 1581-1585

10.1089/end.2021.0103 | PMID 33858196 Get It

Purpose: To investigate the potential for decreasing radiation dose when utilizing a third-generation vs second-generation dual-source dual-energy CT (dsDECT) scanner, while maintaining diagnostic image quality and acceptable image noise. Materials and Methods : Retrospective analysis of patients who underwent dsDECT for clinical suspicion of urolithiasis from October 2, 2017, to September 5, 2018. Patient demographics, body mass index, abdominal diameter, scanning parameters, and CT dose index volume (CTDIvol) were recorded. Image quality was assessed by measuring the attenuation and standard deviation (SD) regions of interest in the aorta and in the bladder. Image noise was determined by averaging the SD at both levels. Patients were excluded if they had not undergone both third- and second-generation dual-energy CT (DECT), time between DECT was more than 2 years, or scan parameters were outside the standard protocol. Results: A total of 117 patients met the inclusion criteria. Examinations performed on a third-generation DECT had an average CTDIvol 12.3 mGy, while examinations performed on a second-generation DECT had an average CTDIvol 13.3 mGy ( p < 0.001). Average image noise was significantly lower for the third-generation DECT (SD = 10.3) compared with the second-generation DECT (SD = 13.9) ( p < 0.001). Conclusions: The third-generation dsDECT scanners can simultaneously decrease patient radiation dose and decrease image noise compared with second-generation DECT. These reductions in radiation exposure can be particularly important in patients with urinary stone disease who often require repeated imaging to evaluate for stone development and recurrence as well as treatment assessment.
Clinical efficacy and safety of magnetic sphincter augmentation (MSA) and transoral incisionless fundoplication (TIF2) in refractory gastroesophageal reflux disease (GERD): a systematic review and meta-analysis
Khan, Shahab R. , Jha, Lokesh K. , Dhaliwal, Amaninder J., Aziz, Muhammad , Arora, Sumant, Malik, Sarah , Kassab, Lena L., Ponnada, Suresh, Bhat, Ishfaq , Hewlett, Alexander , McDonough, Stephanie, Chandan, Saurabh , Mohan, Babu P. , Bilal, Mohammad , Canakis, Andrew , Sharma, Neil, Adler, Douglas G.

Mayo Clinic

Endoscopy International Open | April 14, 2021 | Volume: 09 | Issue: 04 | Pages: E583-E598

10.1055/a-1352-2944 | PMID 33869732 Get It

Abstract Background and study aims Proton pump inhibitors (PPI) are effective medical therapy options for gastro-esophageal reflux disease (GERD). However, 20 % to 40 % of patients report symptoms despite taking daily PPI. Transoral incisionless fundoplication (TIF2) and magnetic sphincter augmentation (MSA) are less invasive options for the treatment of refractory GERD and are increasingly gaining popularity. Methods We conducted a comprehensive search of several databases to identify relevant studies. Our primary aim was to compare the efficacy of both interventions reported as improvement in Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) score, overall patient satisfaction, improvement in post-procedure regurgitation, and fraction of patients completely off PPI therapy at follow up. Results Twenty-four studies with 1942 patients were included in the final analysis. Both MSA and TIF2 had comparable technical success and clinical success based on improvement in GERD-HRQL scores i. e. 98.8 % (CI 95.6,99.7) vs 98.5 % (CI 95.7,99.5) and 80.4 % (CI 66,89.6) vs 77.7 % (CI 64.1,87.2), respectively. A significantly greater proportion of patients reported improvement in regurgitation, i. e. 91.1 % (CI 83.8,95.3) vs 73.1 % (CI 62.5,81.7) and were able to completely discontinue PPI therapy with MSA compared to TIF2 i. e. 91.3 % (CI 81.5,96.2) vs 63.8 % (CI 51.6,74.4). Patients’ BMI and presence of a hiatal hernia did not have any effect on procedural outcomes. Conclusion Both procedures performed at par when comparing clinical success in terms of improvement in GERD-HRQL scores. In terms of overall patient satisfaction, post procedure regurgitation and cumulative number of patients off PPI therapy, MSA outperforms TIF2.
Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)
Lee, Seohyuk , Zhang, Sui , Ou, Fang‐Shu , Wolfe, Eric, Ogino, Shuji , Niedzwiecki, Donna , Mowat, Rex B., Whittom, Renaud , Hantel, Alexander, Benson, Al B. , Atienza, Daniel, Messino, Michael J., Kindler, Hedy L. , Gross, Cary P. , Irwin, Melinda L. , Meyerhardt, Jeffrey A. , Fuchs, Charles S. , Ou, Fang-Shu , Wolfe, Eric G, Ogino, Shuji , Kindler, Hedy , Venook, Alan P , Fuchs, Charles S , Meyerhardt, Jeffrey A , Niedzwiecki, Donna , Ma, Chao , Saltz, Leonard B. , Mayer, Robert J. , Venook, Alan P.

Mayo Clinic

JNCI Cancer Spectrum | April 11, 2021 | Volume: 5 | Issue: 3 | Pages: No page available

10.1093/jncics/pkab034 | PMID 34104867 Get It

Abstract Background Disparities in colon cancer outcomes have been reported across race and socioeconomic status, which may reflect, in part, access to care. We sought to assess the influences of race and median household income (MHI) on outcomes among colon cancer patients with similar access to care. Methods We conducted a prospective, observational study of 1206 stage III colon cancer patients enrolled in the CALGB 89803 randomized adjuvant chemotherapy trial. Race was self-reported by 1116 White and 90 Black patients at study enrollment; MHI was determined by matching 973 patients’ home zip codes with publicly available US Census 2000 data. Multivariate analyses were adjusted for baseline sociodemographic, clinical, dietary, and lifestyle factors. All statistical tests were 2-sided. Results Over a median follow-up of 7.7 years, the adjusted hazard ratios for Blacks (compared with Whites) were 0.94 (95% confidence interval [CI] = 0.66 to 1.35, P = .75) for disease-free survival, 0.91 (95% CI = 0.62 to 1.35, P = .65) for recurrence-free survival, and 1.07 (95% CI = 0.73 to 1.57, P = .73) for overall survival. Relative to patients in the highest MHI quartile, the adjusted hazard ratios for patients in the lowest quartile were 0.90 (95% CI = 0.67 to 1.19, Ptrend = .18) for disease-free survival, 0.89 (95% CI = 0.66 to 1.22, Ptrend = .14) for recurrence-free survival, and 0.87 (95% CI = 0.63 to 1.19, Ptrend = .23) for overall survival. Conclusions In this study of patients with similar health-care access, no statistically significant differences in outcomes were found by race or MHI. The substantial gaps in outcomes previously observed by race and MHI may not be rooted in differences in tumor biology but rather in access to quality care.
The Society for Obstetric Anesthesia and Perinatology Coronavirus Disease 2019 Registry: An Analysis of Outcomes Among Pregnant Women Delivering During the Initial Severe Acute Respiratory Syndrome Coronavirus-2 Outbreak in the United States
Bateman, Brian T. , Kjaer, Klaus, Spence, Nicole Z. , Toledano, Roulhac D. , Grant, Gilbert, Madden, Hannah E., Lynde, Grant C. , Beilin, Yaakov, Kodali, Bhavani Shankar , Bharadwaj, Shobana , Prabhu, Malavika, Gonzales, Nikolai Y., Leffert, Lisa , Katz, Daniel , Kjaer, Klaus, Turner, Dana P. , Habib, Ashraf S. , George, Ronald B. , Butwick, Alexander J. , Minehart, Rebecca D. , Houle, Timothy T. , Sharpe, Emily E. , Farber, Michaela Kristina , Palanisamy, Arvind , Landau, Ruth

Mayo Clinic

Anesthesia & Analgesia | April 8, 2021 | Volume: 133 | Issue: 2 | Pages: 462-473

10.1213/ane.0000000000005592 | PMID 33830956 Get It

BACKGROUND: Early reports associating severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection with adverse pregnancy outcomes were biased by including only women with severe disease without controls. The Society for Obstetric Anesthesia and Perinatology (SOAP) coronavirus disease 2019 (COVID-19) registry was created to compare peripartum outcomes and anesthetic utilization in women with and without SARS-CoV-2 infection delivering at institutions with widespread testing. METHODS: Deliveries from 14 US medical centers, from March 19 to May 31, 2020, were included. Peripartum infection was defined as a positive SARS-CoV-2 polymerase chain reaction test within 14 days of delivery. Consecutive SARS-CoV-2–infected patients with randomly selected control patients were sampled (1:2 ratio) with controls delivering during the same day without a positive test. Outcomes were obstetric (eg, delivery mode, hypertensive disorders of pregnancy, and delivery <37 weeks), an adverse neonatal outcome composite measure (primary), and anesthetic utilization (eg, neuraxial labor analgesia and anesthesia). Outcomes were analyzed using generalized estimating equations to account for clustering within centers. Sensitivity analyses compared symptomatic and asymptomatic patients to controls. RESULTS: One thousand four hundred fifty four peripartum women were included: 490 with SARS-CoV-2 infection (176 [35.9%] symptomatic) and 964 were controls. SARS-CoV-2 patients were slightly younger, more likely nonnulliparous, nonwhite, and Hispanic than controls. They were more likely to have diabetes, obesity, or cardiac disease and less likely to have autoimmune disease. After adjustment for confounders, individuals experiencing SARS-CoV-2 infection exhibited an increased risk for delivery <37 weeks of gestation compared to controls, 73 (14.8%) vs 98 (10.2%) (adjusted odds ratio [aOR], 1.47; 95% confidence interval [CI], 1.03–2.09). Effect estimates for other obstetric outcomes and the neonatal composite outcome measure were not meaningfully different between SARS-CoV-2 patients versus controls. In sensitivity analyses, compared to controls, symptomatic SARS-CoV-2 patients exhibited increases in cesarean delivery (aOR, 1.57; 95% CI, 1.09–2.27), postpartum length of stay (aOR, 1.89; 95% CI, 1.18–2.60), and delivery <37 weeks of gestation (aOR, 2.08; 95% CI, 1.29–3.36). These adverse outcomes were not found in asymptomatic women versus controls. SARS-CoV-2 patients (asymptomatic and symptomatic) were less likely to receive neuraxial labor analgesia (aOR, 0.52; 95% CI, 0.35–0.75) and more likely to receive general anesthesia for cesarean delivery (aOR, 3.69; 95% CI, 1.40–9.74) due to maternal respiratory failure. CONCLUSIONS: In this large, multicenter US cohort study of women with and without peripartum SARS-CoV-2 infection, differences in obstetric and neonatal outcomes seem to be mostly driven by symptomatic patients. Lower utilization of neuraxial analgesia in laboring patients with asymptomatic or symptomatic infection compared to patients without infection requires further investigation.
Prevalence and Trends of Surgical Intervention for Trigeminal Neuralgia in the Inpatient Setting in the United States: Analyses from a National Database from 2002–2015
Alexander, Alexander Y., Doherty, Ronan J. , Yocu, Yagiz U., Kerezoudis, Panagiotis , Agarwal, Vijay , Ghoghawala, Zoher, Link, Michael J. , Meyer, Frederick B., Alvi, Mohammed Ali , Brown, Desmond , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | April 8, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0041-1725348 Get It

Economic Outcomes of Patients Undergoing Surgical Intervention for Trigeminal Neuralgia: Analysis from a National Database
Doherty, Ronan J. , Alexander, Alexander Y., Yocu, Yagiz U., Kerezoudis, Panagiotis , Agarwal, Vijay , Ghoghawala, Zoher, Link, Michael J. , Meyer, Frederic B., Alvi, Mohammed Ali , Brown, Desmond , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | April 8, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0041-1725345 Get It

Utility of Modified Frailty Index (MFI) and Traditional Prognostic Measures to Prognosticate Adverse 30-Day Quality Outcomes after Microvascular Decompression for Trigeminal Neuralgia
Doherty, Ronan J. , Yolcu, Yagiz U. , Alexander, Alexander Y., Kerezoudis, Panagiotis , Agarwal, Vijay , Ghoghawala, Zoher, Link, Michael J. , Meyer, Frederick B., Alvi, Mohammed Ali , Brown, Desmond , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | April 8, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0041-1725269 Get It

Effectiveness of a Weight Loss Program Using Digital Health in Adolescents and Preadolescents
Lei, Sha , Medina‐Inojosa, José R. , Kumar, Seema, Lee, Alexander T., Lerman, Lilach O. , Senecal, Conor , Lin, Weihua, Inojosa, Jose R Medina, Senecal, Conor G, Medina-Inojosa, José R , Scott, Christopher G. , Lerman, Amir , Zhang, Xiaoyong , Cohen, Pinchas , López-Jiménez, Francisco

Mayo Clinic

Childhood Obesity | April 7, 2021 | Volume: 17 | Issue: 5 | Pages: 311-321

10.1089/chi.2020.0317 | PMID 33826417 Get It

Objective: To identify an efficacious intervention on treating adolescents with overweight and obesity, this might result in health benefits. Methods: Adolescents with overweight or obesity aged 10–17 years with BMI percentile ≥85th were included in this historical observational analysis. Subjects used an entirely remote weight loss program combining mobile applications, frequent self-weighing, and calorie restriction with meal replacement. Body weight changes were evaluated at 42, 60, 90, and 120 days using different metrics including absolute body weight, BMI, and BMI z-score. Chi-square or Fisher exact tests (categorical variables) and Student's t -test (continuous variables) were used to compare subjects. Results: In total, 2,825 participants, mean age 14.4 ± 2.2 years, (54.8% girls), were included from October 27, 2016, to December 31, 2017, in mainland China; 1355 (48.0%) had a baseline BMI percentile ≥97th. Mean BMI and BMI z-score were 29.20 ± 4.44 kg/m 2 and 1.89 ± 0.42, respectively. At day 120, mean reduction in body weight, BMI, and BMI z-score was 8.6 ± 0.63 kg, 3.13 ± 0.21 kg/m 2 , and 0.42 ± 0.03; 71.4% had lost ≥5% body weight, 69.4% of boys and 73.2% of girls, respectively. Compared with boys, girls achieved greater reduction on BMI z-score at all intervals ( p < 0.004 for all comparisons). Higher BMI percentile at baseline and increased frequency of use of the mobile application were directly associated with more significant weight loss. Conclusions: An entirely remote digital weight loss program is effective in facilitating weight loss in adolescents with overweight or obesity in the short term and mid term.